Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Symbicort
Generic Name: Budesonide-Formoterol
Budesonide and formoterol combined are a long-acting inhaled corticosteroid that is used to treat asthma where combination therapy is indicated and for airflow obstruction associated with chronic obstructive pulmonary disease (COPD).
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Asthma | 61 | 8 |
|
|
|
||
| COPD (Chronic Obstructive Pulmonary Disease) | 19 | 1 |
|
||||
| Asthma | 18 | 2 |
|
||||
| General health | 4 | 0 | |||||
| Other | 3 | 1 |
|
||||
| Emphysema | 3 | 0 |
See all 119 patients currently taking Budesonide-Formoterol
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Budesonide-Formoterol
| Dry mouth at night | 1 | |
|---|---|---|
| Racing heart feeling | 1 | |
| Weight gain | 1 | |
| Dry mouth (xerostomia) | 1 | |
| Mouth sores (ulcers) | 1 | |
| Acne breakout | 1 | |
| See all 10 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Budesonide-Formoterol. See all 20 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Other | 4 | ||
| Did not seem to work | 3 | ||
| Doctor's advice | 3 | ||
| Course of treatment ended | 2 |
See all 11 patients who’ve stopped taking Budesonide-Formoterol
Adherence
Taking treatment as prescribed
Adherence of Budesonide-Formoterol
Always |
11 | 65% |
|
|---|---|---|---|
Usually |
5 | 29% |
|
Sometimes |
1 | 6% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Budesonide-Formoterol
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
3 | 18% |
|
A little |
5 | 29% |
|
Not at all |
9 | 53% |
|
Cost
Paid out of pocket
Cost of Budesonide-Formoterol
$200+ |
3 | 25% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
1 | 8% |
|
$25-49 |
2 | 17% |
|
< $25 |
5 | 42% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.